HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

T 86

Also Known As:

catena-succinate-diaquadinicotinamide-cobaltdihydrate

Networked: 6 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyridines: 88
    - Nicotinic Acids: 13
      - Niacinamide: 2223
        T 86: 6
- Heterocyclic Acids
  - Nicotinic Acids: 13
    - Niacinamide: 2223
      - T 86: 6
Organic Chemicals: 133
- Organometallic Compounds: 64
  - T 86: 6

Experts

1.	Alışık, Murat: 1 article (01/2018)
2.	Erel, Özcan: 1 article (01/2018)
3.	Göker, Zeynep: 1 article (01/2018)
4.	Güney, Esra: 1 article (01/2018)
5.	Hekim Bozkurt, Özlem: 1 article (01/2018)
6.	Çöp, Esra: 1 article (01/2018)
7.	Üneri, Özden Şükran: 1 article (01/2018)
8.	Şenses Dinç, Gülser: 1 article (01/2018)
9.	Cranswick, Noel E: 1 article (11/2014)
10.	Davidson, Andrew J: 1 article (11/2014)

Related Diseases

1.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/01/2000 - "Intensive chemotherapy followed by treatment with interleukin-2 (IL-2) was evaluated in a prospective, randomized, multicenter trial including 18 patients with refractory anemia with excess of blasts in transformation (RAEB-T), 86 patients with acute myeloid leukemia (AML) evolving from myelodysplastic syndromes, and six patients with secondary AML after previous chemotherapy. "
2.	Seizures (Absence Seizure) 11/01/2014 - "Most participants had normal cranial ultrasounds (T 86% vs P 86%); no seizures occurred clinically or electroencephalographically. "
3.	Personality Disorders (Personality Disorder) 01/01/2022 - "We found that the SA group showed greater severity of SI [t (86) = -3.485, p < 0.001], higher levels of subjective depression [t (70) = -2.65, p = 0.01)], and a higher prevalence of personality disorders [ χ(3)2 = 8.775, p = 0.032] than the SI group. "
4.	Obesity 03/15/2010 - "Egger's test did not find significant evidence for publication bias in the meta-analysis for obesity (t = -1.4, p = .21) or for diabetes (t = -.86, p = .42). "
5.	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/01/2000 - "Intensive chemotherapy followed by treatment with interleukin-2 (IL-2) was evaluated in a prospective, randomized, multicenter trial including 18 patients with refractory anemia with excess of blasts in transformation (RAEB-T), 86 patients with acute myeloid leukemia (AML) evolving from myelodysplastic syndromes, and six patients with secondary AML after previous chemotherapy. "

Related Drugs and Biologics

1.	Interleukin-2 (IL2)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)